Interview With J&J’s CMO Dr Joanne Waldstreicher On Internal And External Challenges To Sharing Clinical Trial Data
Executive Summary
"Everything different and worthwhile comes with its challenges," Johnson & Johnson’s chief medical officer, Joanne Waldstreicher, told the Pink Sheet's Sukaina Virji in an interview about how the company went about engaging in initiatives to share its clinical trial data and make drugs available for compassionate use.
You may also be interested in...
UK Reimbursement Decisions Focus Mostly On Cancer
The UK's main reimbursement bodies made a series of decisions this week that were broadly favorable and largely focused on oncology medicines.
Deal Watch: Valeant Sells Off iNova To Finance Debt-Reduction Efforts
While troubled Valeant was divesting iNova to private equity investors, Novartis announced a pair of oncology-focused deals, out-licensing a brain cancer drug to Midatech and partnering with IBM Watson Health to optimize breast cancer treatment.
Pfizer/Astellas Amend Trial To Position Xtandi In Early Prostate Cancer
Astellas and Pfizer have amended the PROSPER trial protocol in a bid to position Xtandi ahead of Zytiga in the early stage prostate cancer market.